622 related articles for article (PubMed ID: 28400164)
1. Intranasal and sublingual delivery of inactivated polio vaccine.
Kraan H; Soema P; Amorij JP; Kersten G
Vaccine; 2017 May; 35(20):2647-2653. PubMed ID: 28400164
[TBL] [Abstract][Full Text] [Related]
2. Serum and mucosal antibody responses to inactivated polio vaccine after sublingual immunization using a thermoresponsive gel delivery system.
White JA; Blum JS; Hosken NA; Marshak JO; Duncan L; Zhu C; Norton EB; Clements JD; Koelle DM; Chen D; Weldon WC; Oberste MS; Lal M
Hum Vaccin Immunother; 2014; 10(12):3611-21. PubMed ID: 25483682
[TBL] [Abstract][Full Text] [Related]
3. The novel adjuvant dmLT promotes dose sparing, mucosal immunity and longevity of antibody responses to the inactivated polio vaccine in a murine model.
Norton EB; Bauer DL; Weldon WC; Oberste MS; Lawson LB; Clements JD
Vaccine; 2015 Apr; 33(16):1909-15. PubMed ID: 25765967
[TBL] [Abstract][Full Text] [Related]
4. Sublingual immunization with a subunit influenza vaccine elicits comparable systemic immune response as intramuscular immunization, but also induces local IgA and TH17 responses.
Gallorini S; Taccone M; Bonci A; Nardelli F; Casini D; Bonificio A; Kommareddy S; Bertholet S; O'Hagan DT; Baudner BC
Vaccine; 2014 Apr; 32(20):2382-8. PubMed ID: 24434044
[TBL] [Abstract][Full Text] [Related]
5. Surveillance of immunity acquired from poliovirus immunization including vaccination with the Sabin strain-derived inactivated vaccine.
Hotta C; Ogawa T; Shirasawa H
Hum Vaccin Immunother; 2019; 15(5):1154-1159. PubMed ID: 30676843
[TBL] [Abstract][Full Text] [Related]
6. An inactivated poliovirus vaccine using Sabin strains produced on the serum-free PER.C6® cell culture platform is immunogenic and safe in a non-human primate model.
Bockstal V; Tiemessen MM; Achterberg R; Van Wordragen C; Knaapen AM; Serroyen J; Marissen WE; Schuitemaker H; Zahn R
Vaccine; 2018 Nov; 36(46):6979-6987. PubMed ID: 30314910
[TBL] [Abstract][Full Text] [Related]
7. Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine.
Brickley EB; Strauch CB; Wieland-Alter WF; Connor RI; Lin S; Weiner JA; Ackerman ME; Arita M; Oberste MS; Weldon WC; Sáez-Llorens X; Bandyopadhyay AS; Wright PF
J Infect Dis; 2018 Jan; 217(3):371-380. PubMed ID: 29304199
[TBL] [Abstract][Full Text] [Related]
8. Analyzed immunogenicity of fractional doses of Sabin-inactivated poliovirus vaccine (sIPV) with intradermal delivery in rats.
Ma L; Cai W; Sun M; Cun Y; Zhou J; Liu J; Hu W; Zhang X; Song S; Jiang S; Liao G
Hum Vaccin Immunother; 2016 Dec; 12(12):3125-3131. PubMed ID: 27558963
[TBL] [Abstract][Full Text] [Related]
9. Enhanced humoral and cellular immune responses after sublingual immunization against human papillomavirus 16 L1 protein with adjuvants.
Cho HJ; Kim JY; Lee Y; Kim JM; Kim YB; Chun T; Oh YK
Vaccine; 2010 Mar; 28(14):2598-606. PubMed ID: 20116467
[TBL] [Abstract][Full Text] [Related]
10. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
11. Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strains.
Westdijk J; Koedam P; Barro M; Steil BP; Collin N; Vedvick TS; Bakker WA; van der Ley P; Kersten G
Vaccine; 2013 Feb; 31(9):1298-304. PubMed ID: 23313617
[TBL] [Abstract][Full Text] [Related]
12. Alternative delivery of a thermostable inactivated polio vaccine.
Kraan H; Ploemen I; van de Wijdeven G; Que I; Löwik C; Kersten G; Amorij JP
Vaccine; 2015 Apr; 33(17):2030-7. PubMed ID: 25772676
[TBL] [Abstract][Full Text] [Related]
13. A mucosal adjuvant for the inactivated poliovirus vaccine.
Steil BP; Jorquera P; Westdijk J; Bakker WA; Johnston RE; Barro M
Vaccine; 2014 Jan; 32(5):558-63. PubMed ID: 24333345
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: a phase I trial in healthy adults.
Verdijk P; Rots NY; van Oijen MG; Oberste MS; Boog CJ; Okayasu H; Sutter RW; Bakker WA
Vaccine; 2013 Nov; 31(47):5531-6. PubMed ID: 24063976
[TBL] [Abstract][Full Text] [Related]
15. Human Circulating Antibody-Producing B Cell as a Predictive Measure of Mucosal Immunity to Poliovirus.
Dey A; Molodecky NA; Verma H; Sharma P; Yang JS; Saletti G; Ahmad M; Bahl SK; Wierzba TF; Nandy RK; Deshpande JM; Sutter RW; Czerkinsky C
PLoS One; 2016; 11(1):e0146010. PubMed ID: 26730586
[TBL] [Abstract][Full Text] [Related]
16. Skin delivery of trivalent Sabin inactivated poliovirus vaccine using dissolvable microneedle patches induces neutralizing antibodies.
Donadei A; Kraan H; Ophorst O; Flynn O; O'Mahony C; Soema PC; Moore AC
J Control Release; 2019 Oct; 311-312():96-103. PubMed ID: 31484041
[TBL] [Abstract][Full Text] [Related]
17. Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein.
Singh S; Yang G; Byrareddy SN; Barry MA; Sastry KJ
Vaccine; 2014 Dec; 32(51):6934-6940. PubMed ID: 25444819
[TBL] [Abstract][Full Text] [Related]
18. Inducing dose sparing with inactivated polio virus formulated in adjuvant CAF01.
Dietrich J; Andreasen LV; Andersen P; Agger EM
PLoS One; 2014; 9(6):e100879. PubMed ID: 24956110
[TBL] [Abstract][Full Text] [Related]
19. Alkyl polyglycoside, a highly promising adjuvant in intranasal split influenza vaccines.
Wu H; Bao Y; Wang X; Zhou D; Wu W
Hum Vaccin Immunother; 2017 Jun; 13(6):1-9. PubMed ID: 28129034
[TBL] [Abstract][Full Text] [Related]
20. Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection.
Hong SH; Byun YH; Nguyen CT; Kim SY; Seong BL; Park S; Woo GJ; Yoon Y; Koh JT; Fujihashi K; Rhee JH; Lee SE
Vaccine; 2012 Jan; 30(2):466-74. PubMed ID: 22051136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
